Lead Sponsor

Bristol-Myers Squibb

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Yes

•For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
•Healthy as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations in the opinion of the investigator
•Body mass index of 18.0 to 32.0 kg/m2, inclusive, and body weight ≥ 50 kg, at screening
•Normal renal function at screening as evidenced by an estimated glomerular filtration rate (GFR) \> 80 mL/min/1.732 m2

•Any medical condition that presents a potential risk and/or may compromise the objectives of the study, including a history or presence of active liver disease
•A personal history of clinically relevant cardiac disease as determined by the investigator, symptomatic or asymptomatic arrhythmias, presyncope or syncopal episodes, or additional risk factors for torsades de pointes (eg, heart failure)
•History of hypokalemia, personal history or family history of prolonged QT interval, or family history of sudden cardiac death at a young age

Related studies

NCT07409181 · Systemic Lupus Erythematosus

NCT07043153 · Systemic Lupus Erythematosus Disease

NCT07554365 · Healthy Volunteer, Healthy Participants Study

NCT05869955 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, and more

NCT07558850 · Rheumatoid Arthritis, Dermatomyositis, and more

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects